Key result
Angiotensin-converting enzyme inhibitors have proven effects on life prognosis after myocardial infarction, with various therapeutic tactics guiding the choice of specific agents.
Why the study?
Do ACE inhibitors improve life prognosis in post myocardial infarction patients?
Do ACE inhibitors improve life prognosis in post myocardial infarction patients?
This review summarizes evidence supporting the use of ACE inhibitors to improve prognosis in patients after myocardial infarction.
Answers are grounded in this paper and cite their sources.
Supports ACE inhibitor use post-MI for prognosis; leaves open optimal agent selection pending prospective trials.
The main trails proven angiotensin converting enzyme (ACE) inhibitor effects on the life prognosis after myocardial infarction (MI) are described. Different tactics of ACE inhibitors therapy in post MI patients are presented. Approaches to the choice of a specific ACE inhibitor are discussed.
No takes yet. Share an insight, caveat, or question.
S. Yu. Martsevich (2010) studied this question. Angiotensin-converting enzyme inhibitors have proven effects on life prognosis after myocardial infarction, with various therapeutic tactics guiding the choice of specific agents.
Synapse has enriched 10 related papers. Consider them for comparative context: